Chronic Hepatitis C virus infection in Swiss primary care practices: Low case loads-high barriers to treatment?

被引:4
作者
Overbeck, Kathrin [2 ]
Bruggmann, Philip [3 ]
Helbling, Beat [1 ]
机构
[1] Stadtspital Waid, Dept Gastroenterol & Hepatol, CH-8037 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Internal Med, Zurich, Switzerland
[3] ARUD Assoc Risk Reduct Drugs, Zurich, Switzerland
关键词
Hepatitis C; primary care physician; disease workup; patient monitoring; barriers to treatment; THERAPY; MANAGEMENT; PREDICTORS; PHYSICIANS; PATIENT; RATES;
D O I
10.3109/13814788.2010.545122
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: The primary care physician (PCP) diagnoses chronic Hepatitis C virus (HCV) infection in most patients. He serves as gatekeeper and plays a key role in counselling and treatment guidance. Objectives: To calculate the approximate HCV caseload per practice and characterize PCPs management of the disease; in particular, to determine antiviral treatment rates and reasons for PCPs for withholding treatment. The ultimate objective was to identify potentially modifiable barriers to treatment. Methods: A confidential self-administered questionnaire centred on the above-mentioned questions was distributed to 2371 Swiss primary care physicians. All respondents of the main questionnaire received an additional small questionnaire focussed on the initial disease workup. Descriptive statistics were used to describe questionnaire responses and PCP demographics. Results : The response rate was 53.1%. Of all participating PCPs (n = 1084), 86.2% reported having patients with chronic HCV, with an average number of 4 patients per practice; 18.6% (n = 142) of PCPs did not monitor their chronic HCV patients. Two-thirds (66.8%) of the sample chronic HCV patient population (n = 4626) never received antiviral therapy. The main reasons given by PCPs for withholding treatment were HCV-specialist advice, patient preference, normal liver enzymes and patient related factors like substance abuse or psychiatric co morbidity. Conclusions: Most PCPs follow patients with chronic hepatitis C, but practice caseloads are low, which may account for insecurity in managing this complex disease.
引用
收藏
页码:103 / 108
页数:6
相关论文
共 50 条
  • [11] A Review of the Treatment of Chronic Hepatitis C Virus Infection in Cirrhosis
    Vezali, Elena
    Aghemo, Alessio
    Colombo, Massimo
    CLINICAL THERAPEUTICS, 2010, 32 (13) : 2117 - 2138
  • [12] Hepatitis C virus infection: opportunities for an earlier detection in primary care
    Lapi, Francesco
    Sansone, Alice Capogrosso
    Mantarro, Stefania
    Simonetti, Monica
    Tuccori, Marco
    Blandizzi, Corrado
    Rossi, Alessandro
    Corti, Giampaolo
    Bartoloni, Alessandro
    Bellia, Alfonso
    Baiocchi, Leonardo
    Cricelli, Iacopo
    Cricelli, Claudio
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (03) : 271 - 276
  • [13] Using Surveillance Data to Determine Treatment Rates and Outcomes for Patients With Chronic Hepatitis C Virus Infection
    Lattimore, Sam
    Irving, Will
    Collins, Sarah
    Penman, Celia
    Ramsay, Mary
    HEPATOLOGY, 2014, 59 (04) : 1343 - 1350
  • [14] Evaluation of immigration status, race and language barriers on chronic hepatitis C virus infection management and treatment outcomes
    Giordano, Celine
    Druyts, Eric F.
    Garber, Gary
    Cooper, Curtis
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (09) : 963 - 968
  • [15] Patients receiving opioid maintenance treatment in primary care: successful chronic hepatitis C care in a real world setting
    Seidenberg, Andre
    Rosemann, Thomas
    Senn, Oliver
    BMC INFECTIOUS DISEASES, 2013, 13
  • [16] Patterns and predictors of treatment initiation and completion in patients with chronic hepatitis C virus infection
    Clark, Brian T.
    Garcia-Tsao, Guadalupe
    Fraenkel, Liana
    PATIENT PREFERENCE AND ADHERENCE, 2012, 6 : 285 - 295
  • [17] Treatment of chronic hepatitis C virus infection. A study of best predictors for response
    Ospina Vanegas, Nataly
    Rodriguez San Roman, Jose Luis
    Hernandez Febles, Melisa
    Garcia Sanchez, Claudio
    Martin Suarez, Jose Maria
    Redondo Martinez, Elena
    Olivia Hernandez, Leonor
    Pena Lopez, Maria Jose
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2011, 24 (04) : 198 - 203
  • [18] Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection
    Ahmed, Rowan
    Kareem, Roaa
    Venkatesan, Nanditha
    Botleroo, Rinky A.
    Ogeyingbo, Opemipo D.
    Bhandari, Renu
    Gyawali, Mallika
    Elshaikh, Abeer O.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [19] Chronic Hepatitis C Virus Infection: An Ongoing Challenge in Screening and Treatment
    Tsai, Wei-Chu
    Chiang, Hseuh-Chien
    Chiu, Yen-Cheng
    Chien, Shih-Chieh
    Cheng, Pin-Nan
    Chiu, Hung-Chih
    LIFE-BASEL, 2023, 13 (10):
  • [20] Future directions in the treatment of patients with chronic hepatitis C virus infection
    Gish, RG
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 13 (01) : 57 - 62